Niusule Biotech Corp. is a rapidly emerging China-based bio-pharmaceutical company focusing on animal-health products and human nutraceutical supplements. The company’s human product line has a retail distribution network of 226 outlets throughout China, including supermarkets and shopping malls.
The company today announced a distribution agreement with China Nepstar Chain Drugstore Ltd., China’s largest retail drugstore chain based on the number of directly operated stores. The agreement took effect August 25 and calls for the distribution of Niusule’s nutrition supplement product Gummy Bear in Nepstar’s 55 stores in Hangzhou. In the future, Niusule said it expects to extend sales through Nepstar’s extensive network to Shanghai, Ninbo, Tianjing and Suzhou.
Amy Hu, CEO of Niusule, praised Nepstar’s industry experience and professionalism, and said the company will complement Niusule’s expansion efforts.
“We are honored that Nepstar has chosen our Gummy Bear products to expand its fine selection of nutrition supplement products nationally,” Hu stated in the press release. “Their professional sales team and reputation for outstanding customer service in the drugstore industry, coupled with their years of extensive business and trade experience will be a valuable asset for the growth and the promotion of the Gummy Bear. The domestic nutrition product market for children is extremely large and we believe that the cooperation with Nepstar will be a tremendous asset as we continue to expand our footprint in the industry.”
For more information visit www.niusule.com
About QualityStocks:
QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.
Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment